{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:39:02Z","timestamp":1794973142404,"version":"4.9.1"},"reference-count":111,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,20]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The metabolic-immune interplay within the tumor microenvironment (TME) is a critical determinant of tumor progression and immune evasion, presenting significant therapeutic opportunities for enhancing antitumor immunity. The TME is characterized by hypoxia, acidosis, and nutrient depletion, and is also profoundly shaped by the metabolic reprogramming of cancer cells, including enhanced glycolysis, as well as amino acid and lipid metabolism. These metabolic alterations establish an immunosuppressive niche, restricting nutrient availability for effector T cells while enriching the environment with metabolites such as lactate, kynurenine, and adenosine. These metabolites impair the function of cytotoxic T lymphocytes and natural killer cells, while also promoting the survival and activity of regulatory T cells, tumor-associated macrophages, and myeloid-derived suppressor cells. Immune cell function within this challenging milieu is dictated by metabolic adaptability: Effector T cells succumb to metabolic exhaustion, whereas regulatory T cells, tumor-associated macrophages, and myeloid-derived suppressor cells exhibit metabolic flexibility that sustains their survival and suppressive functions. Therapeutic strategies that target cancer cell metabolism or enhance the metabolic fitness of immune cells offer promising approaches to mitigating immunosuppression within the TME. Notably, combining metabolic modulators with existing immunotherapies holds great potential for amplifying antitumor responses. Nonetheless, critical hurdles for clinical translation remain, including target specificity, potential toxicities, and adaptive metabolic plasticity. Further investigation into metabolic reprogramming and precision immunotherapy, guided by emerging biomarkers, is critical for optimizing therapeutic efficacy and improving patient outcomes by fully leveraging the metabolic-immune axis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003908","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:00:12Z","timestamp":1764763212000},"page":"3317-3331","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Metabolic-immune nexus in tumor microenvironment: From mechanistic insights to therapeutic opportunities"],"prefix":"10.1097","volume":"138","author":[{"given":"Wenjie","family":"Zhu","sequence":"first","affiliation":[{"name":"Key Laboratory for Experimental Teratology of Ministry of Education, Department of Pathology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, China"},{"name":"Department of Pathology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchen","family":"Chu","sequence":"additional","affiliation":[{"name":"Key Laboratory for Experimental Teratology of Ministry of Education, Department of Pathology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[{"name":"Key Laboratory for Experimental Teratology of Ministry of Education, Department of Pathology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, China"},{"name":"Department of Pathology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"R1-20260407","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1097\/CM9.0000000000003442","article-title":"Comparative analysis of cancer statistics in China and the United States in 2024","volume":"24","author":"Wu","year":"2024","journal-title":"Chin Med J"},{"key":"R2-20260407","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"R3-20260407","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41571-024-00891-1","article-title":"Multiparametric MRI for characterization of the tumour microenvironment","volume":"21","author":"Hoffmann","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"R4-20260407","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12943-022-01670-1","article-title":"Targeting the tumor stroma for cancer therapy","volume":"21","author":"Xu","year":"2022","journal-title":"Mol Cancer"},{"key":"R5-20260407","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"key":"R6-20260407","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: Insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol Cancer"},{"key":"R7-20260407","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","article-title":"Metabolites and the tumour microenvironment: From cellular mechanisms to systemic metabolism","volume":"3","author":"Elia","year":"2021","journal-title":"Nat Metab"},{"key":"R8-20260407","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2021.03.033","article-title":"CD4+ T-cell differentiation and function: Unifying glycolysis, fatty acid oxidation, polyamines NAD mitochondria","volume":"148","author":"Almeida","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"R9-20260407","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"key":"R10-20260407","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.7150\/thno.105276","article-title":"Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: targets and therapeutic strategies","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"R11-20260407","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40364-024-00646-1","article-title":"Metabolic reprogramming and immune evasion: The interplay in the tumor microenvironment","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomark Res"},{"key":"R12-20260407","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41587-025-02645-5","article-title":"Spotlight on cancer immunotherapies","volume":"43","year":"2025","journal-title":"Nat Biotechnol"},{"key":"R13-20260407","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: Tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R14-20260407","doi-asserted-by":"crossref","first-page":"e2210161","DOI":"10.1002\/adma.202210161","article-title":"Attenuating metabolic competition of tumor cells for favoring the nutritional demand of immune cells by a branched polymeric drug delivery system","volume":"35","author":"Li","year":"2023","journal-title":"Adv Mater"},{"key":"R15-20260407","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41571-024-00926-7","article-title":"Spatial landscapes of cancers: Insights and opportunities","volume":"21","author":"Chen","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"R16-20260407","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"R17-20260407","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R18-20260407","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.semcancer.2022.07.003","article-title":"Historical perspective of tumor glycolysis: A century with Otto Warburg","volume":"86","author":"Bononi","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"R19-20260407","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41568-024-00736-0","article-title":"Targeting the tumour vasculature: from vessel destruction to promotion","volume":"24","author":"Guelfi","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"R20-20260407","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"R21-20260407","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"R22-20260407","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.tcb.2023.03.013","article-title":"The Warburg effect: A signature of mitochondrial overload","volume":"33","author":"Wang","year":"2023","journal-title":"Trends Cell Biol"},{"key":"R23-20260407","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ccell.2021.06.006","article-title":"Is glucose the scapegoat for tumor evasion?","volume":"39","author":"Raines","year":"2021","journal-title":"Cancer Cell"},{"key":"R24-20260407","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R25-20260407","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","article-title":"Lactate: A key regulator of the immune response","volume":"58","author":"Llibre","year":"2025","journal-title":"Immunity"},{"key":"R26-20260407","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","article-title":"Lactylation in cancer: Current understanding and challenges","volume":"42","author":"Li","year":"2024","journal-title":"Cancer Cell"},{"key":"R27-20260407","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.tem.2022.07.004","article-title":"Understanding lactate sensing and signalling","volume":"33","author":"Certo","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"R28-20260407","doi-asserted-by":"crossref","first-page":"217156","DOI":"10.1016\/j.canlet.2024.217156","article-title":"Glycolysis, the sweet appetite of the tumor microenvironment","volume":"600","author":"Kooshan","year":"2024","journal-title":"Cancer Lett"},{"key":"R29-20260407","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-023-01569-3","article-title":"Amino acid metabolism in health and disease","volume":"8","author":"Ling","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R30-20260407","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp Mol Med"},{"key":"R31-20260407","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","article-title":"Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"R32-20260407","doi-asserted-by":"crossref","first-page":"e1731","DOI":"10.1002\/ctm2.1731","article-title":"Harnessing CD8+ T cell dynamics in hepatitis B virus-associated liver diseases: Insights, therapies and future directions","volume":"14","author":"Yue","year":"2024","journal-title":"Clin Transl Med"},{"key":"R33-20260407","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab"},{"key":"R34-20260407","doi-asserted-by":"crossref","first-page":"e148549","DOI":"10.1172\/JCI148549","article-title":"Fighting in a wasteland: Deleterious metabolites and antitumor immunity","volume":"132","author":"Watson","year":"2022","journal-title":"J Clin Invest"},{"key":"R35-20260407","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s42255-020-00329-9","article-title":"The ins and outs of serine and glycine metabolism in cancer","volume":"3","author":"Geeraerts","year":"2021","journal-title":"Nat Metab"},{"key":"R36-20260407","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tips.2024.03.002","article-title":"Targeting methionine metabolism in cancer: Opportunities and challenges","volume":"45","author":"Bin","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"R37-20260407","doi-asserted-by":"crossref","first-page":"102294","DOI":"10.1016\/j.arr.2024.102294","article-title":"Lipids and lipid metabolism in cellular senescence: Emerging targets for age-related diseases","volume":"97","author":"Zeng","year":"2024","journal-title":"Ageing Res Rev"},{"key":"R38-20260407","doi-asserted-by":"crossref","first-page":"188394","DOI":"10.1016\/j.bbcan.2020.188394","article-title":"Cholesterol metabolism: New functions and therapeutic approaches in cancer","volume":"1874","author":"Xu","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R39-20260407","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/imr.13215","article-title":"Lipid metabolism in dendritic cell biology","volume":"317","author":"You","year":"2023","journal-title":"Immunol Rev"},{"key":"R40-20260407","doi-asserted-by":"crossref","first-page":"101165","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog Lipid Res"},{"key":"R41-20260407","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.trecan.2023.08.006","article-title":"Extracellular vesicle lipids in cancer immunoevasion","volume":"9","author":"Chen","year":"2023","journal-title":"Trends Cancer"},{"key":"R42-20260407","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","article-title":"The role of lipids in cancer progression and metastasis","volume":"34","author":"Martin-Perez","year":"2022","journal-title":"Cell Metab"},{"key":"R43-20260407","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.immuni.2024.03.019","article-title":"Ironing out the role of ferroptosis in immunity","volume":"57","author":"Bell","year":"2024","journal-title":"Immunity"},{"key":"R44-20260407","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2024.04.007","article-title":"Emerging targets in lipid metabolism for cancer therapy","volume":"45","author":"Terry","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"R45-20260407","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41582-024-00967-7","article-title":"IDH inhibition in gliomas: From preclinical models to clinical trials","volume":"20","author":"Rud\u00e0","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"R46-20260407","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jare.2024.04.016","article-title":"Abnormal changes in metabolites caused by m6A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application","volume":"70","author":"Zhao","year":"2025","journal-title":"J Adv Res"},{"key":"R47-20260407","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.cmet.2025.03.004","article-title":"Gang of 3: How the Krebs cycle-linked metabolites itaconate, succinate, and fumarate regulate macrophages and inflammation","volume":"37","author":"P\u00e5lsson-McDermott","year":"2025","journal-title":"Cell Metab"},{"key":"R48-20260407","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"R49-20260407","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk7399","article-title":"Activation and antitumor immunity of CD8+ T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid","volume":"16","author":"Liu","year":"2024","journal-title":"Sci Transl Med"},{"key":"R50-20260407","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8+ T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"R51-20260407","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T Cell Exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"R52-20260407","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"R53-20260407","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.immuni.2022.10.006","article-title":"Regulatory T cells as metabolic sensors","volume":"55","author":"de Candia","year":"2022","journal-title":"Immunity"},{"key":"R54-20260407","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","article-title":"Regulatory T cell development","volume":"38","author":"Savage","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"R55-20260407","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","article-title":"Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity","volume":"15","author":"Yan","year":"2022","journal-title":"J Hematol Oncol"},{"key":"R56-20260407","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s41423-024-01216-z","article-title":"Macrophage diversity in cancer dissemination and metastasis","volume":"21","author":"Mantovani","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"R57-20260407","doi-asserted-by":"crossref","first-page":"1444964","DOI":"10.3389\/fimmu.2024.1444964","article-title":"Macrophage polarization and its impact on idiopathic pulmonary fibrosis","volume":"15","author":"Ge","year":"2024","journal-title":"Front Immunol"},{"key":"R58-20260407","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13046-023-02832-9","article-title":"Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming","volume":"42","author":"Zeng","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"R59-20260407","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s43018-025-00909-2","article-title":"Linking macrophage metabolism to function in the tumor microenvironment","volume":"6","author":"Jin","year":"2025","journal-title":"Nat Cancer"},{"key":"R60-20260407","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12943-025-02249-2","article-title":"Harnessing myeloid cells in cancer","volume":"24","author":"Park","year":"2025","journal-title":"Mol Cancer"},{"key":"R61-20260407","doi-asserted-by":"crossref","first-page":"107811","DOI":"10.1016\/j.phrs.2025.107811","article-title":"Decoding the metabolic-immune axis: Neutrophil glycolysis-driven tumor niche remodeling and its therapeutic exploitation","volume":"217","author":"Ma","year":"2025","journal-title":"Pharmacol Res"},{"key":"R62-20260407","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy","volume":"24","author":"He","year":"2025","journal-title":"Mol Cancer"},{"key":"R63-20260407","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41423-020-00556-w","article-title":"Implications of metabolism-driven myeloid dysfunctions in cancer therapy","volume":"18","author":"Strauss","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R64-20260407","doi-asserted-by":"crossref","first-page":"217385","DOI":"10.1016\/j.canlet.2024.217385","article-title":"Tumor microenvironment: Nurturing cancer cells for immunoevasion and druggable vulnerabilities for cancer immunotherapy","volume":"611","author":"Yu","year":"2024","journal-title":"Cancer Lett"},{"issue":"1","key":"R65-20260407","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10565-025-10012-y","article-title":"Myeloid cells are involved in tumor immunity, metastasis and metabolism in tumor microenvironment","volume":"41","author":"Zhang","year":"2025","journal-title":"Cell Biol Toxicol"},{"key":"R66-20260407","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cmet.2019.08.013","article-title":"Mechanisms and implications of metabolic heterogeneity in cancer","volume":"30","author":"Kim","year":"2019","journal-title":"Cell Metab"},{"key":"R67-20260407","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41577-024-01098-2","article-title":"The roles of arginases and arginine in immunity","volume":"25","author":"Can\u00e8","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"R68-20260407","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.chembiol.2023.08.011","article-title":"Tumor microenvironmental nutrients, cellular responses, and cancer","volume":"30","author":"Lobel","year":"2023","journal-title":"Cell Chem Biol"},{"key":"R69-20260407","doi-asserted-by":"crossref","first-page":"114652","DOI":"10.1016\/j.celrep.2024.114652","article-title":"Beyond mitochondrial transfer, cell fusion rescues metabolic dysfunction and boosts malignancy in adenoid cystic carcinoma","volume":"43","author":"Qiao","year":"2024","journal-title":"Cell Rep"},{"key":"R70-20260407","doi-asserted-by":"crossref","first-page":"216837","DOI":"10.1016\/j.canlet.2024.216837","article-title":"The emerging role of lactate in tumor microenvironment and its clinical relevance","volume":"590","author":"Chen","year":"2024","journal-title":"Cancer Lett"},{"key":"R71-20260407","doi-asserted-by":"crossref","first-page":"189005","DOI":"10.1016\/j.bbcan.2023.189005","article-title":"Adenosine in cancer immunotherapy: Taking off on a new plane","volume":"1878","author":"Zhang","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R72-20260407","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"key":"R73-20260407","doi-asserted-by":"crossref","first-page":"1266973","DOI":"10.3389\/fcell.2023.1266973","article-title":"Succinate metabolism: A promising therapeutic target for inflammation, ischemia\/reperfusion injury and cancer","volume":"11","author":"Zhang","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"R74-20260407","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: Linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"R75-20260407","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13045-023-01430-8","article-title":"Novel strategies for cancer immunotherapy: Counter-immunoediting therapy","volume":"16","author":"Liu","year":"2023","journal-title":"J Hematol Oncol"},{"key":"R76-20260407","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41419-023-05937-3","article-title":"Effects of altered glycolysis levels on CD8+ T cell activation and function","volume":"14","author":"Cao","year":"2023","journal-title":"Cell Death Dis"},{"key":"R77-20260407","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front Immunol"},{"key":"R78-20260407","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41420-021-00401-7","article-title":"Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment","volume":"7","author":"Yu","year":"2021","journal-title":"Cell Death Discov"},{"key":"R79-20260407","doi-asserted-by":"crossref","first-page":"115540","DOI":"10.1016\/j.celrep.2025.115540","article-title":"Unraveling the nexus: Genomic instability and metabolism in cancer","volume":"44","author":"Gujar","year":"2025","journal-title":"Cell Rep"},{"key":"R80-20260407","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.ircmb.2021.05.004","article-title":"Genomic instability and metabolism in cancer","volume":"364","author":"Li","year":"2021","journal-title":"Int Rev Cell Mol Biol"},{"key":"R81-20260407","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/s41401-024-01304-w","article-title":"Targeting metabolism to enhance immunotherapy within tumor microenvironment","volume":"45","author":"Liang","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"R82-20260407","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/1538-7445.AM2025-873","article-title":"Abstract 873: 2-deoxy-D-glucose sensitizes the antigen recognition of chimeric antigen receptor-expressing tumor-infiltrating lymphocytes toward hepatocellular carcinoma cells","volume":"85","author":"Liu","year":"2025","journal-title":"Cancer Res"},{"key":"R83-20260407","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1038\/s41467-023-41016-z","article-title":"Rescue of dendritic cells from glycolysis inhibition improves cancer immunotherapy in mice","volume":"14","author":"Inamdar","year":"2023","journal-title":"Nat Commun"},{"key":"R84-20260407","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s43018-024-00811-3","article-title":"Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: A phase 1b\/2 clinical trial and correlative analyses","volume":"5","author":"DiNardo","year":"2024","journal-title":"Nat Cancer"},{"key":"R85-20260407","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7150\/thno.103376","article-title":"Metabolism of cancer cells and immune cells in the initiation, progression, and metastasis of cancer","volume":"15","author":"Jiang","year":"2025","journal-title":"Theranostics"},{"key":"R86-20260407","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1038\/s41467-023-43079-4","article-title":"Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"key":"R87-20260407","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-025-01532-5","article-title":"Synergistic targeting of cancer cells through simultaneous inhibition of key metabolic enzymes","author":"Dreute","year":"2025","journal-title":"Cell Death Differ"},{"key":"R88-20260407","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/JCO.2021.39.3_suppl.311","article-title":"A phase I\/II study of safety and efficacy of the arginase inhibitor INCB001158 plus chemotherapy in patients (Pts) with advanced biliary tract cancers","volume":"39","author":"Javle","year":"2021","journal-title":"J Clin Oncol"},{"key":"R89-20260407","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1158\/1535-7163.MCT-22-0721","article-title":"Arginase 1\/2 inhibitor OATD-02: From discovery to first-in-man setup in cancer immunotherapy","volume":"22","author":"Borek","year":"2023","journal-title":"Mol Cancer Ther"},{"key":"R90-20260407","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S2468-1253(24)00246-2","article-title":"Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: A multicentre, double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Loomba","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R91-20260407","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev-cancerbio-030419-033635","article-title":"Is there a clinical future for IDO1 inhibitors after the failure of epacadostat in melanoma?","volume":"4","author":"Van den Eynde","year":"2020","journal-title":"Ann Rev Cancer Biol"},{"key":"R92-20260407","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.apsb.2024.11.001","article-title":"Reversing metabolic reprogramming by CPT1 inhibition with etomoxir promotes cardiomyocyte proliferation and heart regeneration via DUSP1 ADP-ribosylation-mediated p38 MAPK phosphorylation","volume":"15","author":"Tang","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"R93-20260407","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1158\/1078-0432.CCR-24-0499","article-title":"A phase Ib\/II randomized clinical trial of oleclumab with or without durvalumab plus chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma","volume":"30","author":"Coveler","year":"2024","journal-title":"Clin Cancer Res"},{"key":"R94-20260407","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41586-024-08290-3","article-title":"Evolution of myeloid-mediated immunotherapy resistance in prostate cancer","volume":"637","author":"Lyu","year":"2025","journal-title":"Nature"},{"key":"R95-20260407","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1016\/j.cell.2024.08.021","article-title":"Metformin decelerates aging clock in male monkeys","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"R96-20260407","doi-asserted-by":"crossref","first-page":"e70378","DOI":"10.1111\/jcmm.70378","article-title":"Decrypting the possible mechanistic role of fenofibrate in alzheimer\u2019s disease and type 2 diabetes: The truth and mystery","volume":"29","author":"Alsaleem","year":"2025","journal-title":"J Cell Mol Med"},{"key":"R97-20260407","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12933-024-02119-z","article-title":"The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1\/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7","volume":"23","author":"Chen","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"R98-20260407","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.7150\/ijbs.110406","article-title":"Enhancing CAR-T cell metabolic fitness and memory phenotype for improved efficacy against hepatocellular carcinoma","volume":"21","author":"You","year":"2025","journal-title":"Int J Biol Sci"},{"key":"R99-20260407","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.tibs.2024.08.002","article-title":"New opportunities to overcome T cell dysfunction: The role of transcription factors and how to target them","volume":"49","author":"Wu","year":"2024","journal-title":"Trends Biochem Sci"},{"key":"R100-20260407","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1038\/s41467-024-50485-9","article-title":"C-JUN overexpressing CAR-T cells in acute myeloid leukemia: Preclinical characterization and phase I trial","volume":"15","author":"Zuo","year":"2024","journal-title":"Nat Commun"},{"key":"R101-20260407","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-021-00831-w","article-title":"Ketogenic diet for human diseases: The underlying mechanisms and potential for clinical implementations","volume":"7","author":"Zhu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R102-20260407","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41591-023-02287-7","article-title":"Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: A randomized controlled trial","volume":"29","author":"Teong","year":"2023","journal-title":"Nat Med"},{"key":"R103-20260407","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41467-023-36630-w","article-title":"Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism","volume":"14","author":"Upadhyayula","year":"2023","journal-title":"Nat Commun"},{"key":"R104-20260407","doi-asserted-by":"crossref","first-page":"115234","DOI":"10.1016\/j.celrep.2025.115234","article-title":"Emerging insights into the impact of systemic metabolic changes on tumor-immune interactions","volume":"44","author":"Cote","year":"2025","journal-title":"Cell Rep"},{"key":"R105-20260407","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.molmed.2023.04.004","article-title":"Dietary interventions and precision nutrition in cancer therapy","volume":"29","author":"Mart\u00ednez-Garay","year":"2023","journal-title":"Trends Mol Med"},{"key":"R106-20260407","doi-asserted-by":"crossref","first-page":"1409414","DOI":"10.3389\/fimmu.2024.1409414","article-title":"Eating away cancer: The potential of diet and the microbiome for shaping immunotherapy outcome","volume":"15","author":"Nguyen","year":"2024","journal-title":"Front Immunol"},{"key":"R107-20260407","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13045-023-01453-1","article-title":"Amino acid metabolism in immune cells: Essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy","volume":"16","author":"Yang","year":"2023","journal-title":"J Hematol Oncol"},{"key":"R108-20260407","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.it.2024.05.006","article-title":"Targeting metabolic pathways to counter cancer immunotherapy resistance","volume":"45","author":"Agarwala","year":"2024","journal-title":"Trends Immunol"},{"key":"R109-20260407","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3390\/cancers16132478","article-title":"Emerging therapeutic strategies to overcome drug resistance in cancer cells","volume":"16","author":"Garg","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R110-20260407","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R111-20260407","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-immunol-101220-031513","article-title":"Systems immunology approaches to metabolism","volume":"41","author":"Mogilenko","year":"2023","journal-title":"Annu Rev Immunol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:02:32Z","timestamp":1775592152000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":111,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003908","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"2025-05-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}